In the same context, previous reports showed that a CML treatment led to significant increase in the extent of glycation of HDL and apoA-I, accompanied by severe proteolytic degradation [16,17]. Here, APOA1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.